Dr.Madhukar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 12.66%
- Profit Growth -72.32%
- Ebitda -221.28%
- Net Worth 0.88%
- Total Assets -79.05%
About Dr.Madhukar Pharmaceuticals
Dr.Madhukar Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2014 and has a history of Ten years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2014PTC258454
-
Company No.
258454
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Sep 2014
-
Date of AGM
23 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Dr.Madhukar Pharmaceuticals Private Limited offer?
Dr.Madhukar Pharmaceuticals Private Limited offers a wide range of products and services, including Fitness Supplements, Energy Supplement, Nutraceuticals & Dietary Supplements, Mineral Supplement, Calcium Supplements, Physiotherapy & Rehab Aids, Rehabilitation Equipment.
Who are the key members and board of directors at Dr.Madhukar Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandhya Chodankar
|
Director | 30-Sep-2014 | Current |
|
Prasad Chodankar
|
Director | 30-Sep-2014 | Current |
Financial Performance of Dr.Madhukar Pharmaceuticals.
Dr.Madhukar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.66% increase. The company also saw a substantial fall in profitability, with a 72.32% decrease in profit. The company's net worth moved up by a moderate rise of 0.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Madhukar Pharmaceuticals?
In 2020, Dr.Madhukar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Madhukar Hormones & Steroids Private LimitedSandhya Chodankar and Prasad Chodankar are mutual person
-
Hegenlife Remedies Private LimitedPrasad Chodankar is a mutual person
Charges (Loans)
₹0
₹4.00 M
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2017 | Others | ₹4.00 M | Satisfied |
How Many Employees Work at Dr.Madhukar Pharmaceuticals?
Unlock and access historical data on people associated with Dr.Madhukar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Madhukar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Madhukar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.